Medtronic plc. · BMV:MDT/N

Medtronic plc. financial statements

Medtronic plc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue36.4B33.5B32.4B31.2B31.7B30.1B28.9B30.6B30.0B29.7B
Cost of revenue12.7B11.6B11.2B10.7B10.1B10.5B9.42B9.15B9.07B9.29B
Gross profit23.6B21.9B21.1B20.5B21.5B19.6B19.5B21.4B20.9B20.4B
Research and development2.87B2.73B2.73B2.70B2.75B2.49B2.33B2.33B2.26B2.19B
Selling, general and administrative11.8B10.8B10.7B10.4B10.3B10.1B10.1B10.4B10.2B10.0B
Operating income6.47B5.96B5.14B5.49B5.75B4.48B4.79B6.27B6.64B5.38B
Depreciation and amortization2.96B2.86B2.65B2.70B2.71B2.70B2.66B2.66B2.64B2.92B
EBITDA9.43B8.82B7.79B8.18B8.46B7.19B7.45B8.93B9.28B8.30B
Interest expense715.0M729.0M719.0M636.0M553.0M925.0M1.09B1.44B1.15B1.09B
Income before tax6.14B5.63B4.84B5.36B5.52B3.90B4.05B5.20B5.67B4.60B
Income tax1.30B936.0M1.13B1.58B456.0M265.0M-751.0M547.0M2.58B578.0M
Net income4.80B4.66B3.68B3.76B5.04B3.61B4.79B4.63B3.10B4.03B
Earnings per share, basic3.753.632.772.833.752.683.573.442.292.92
Earnings per share, diluted3.733.612.762.823.732.663.543.412.272.89

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents1.95B2.22B1.28B1.54B3.71B3.59B4.14B4.39B3.67B4.97B
Short-term investments7.27B6.75B6.72B6.42B6.86B7.22B6.81B5.46B7.56B8.74B
Receivables6.64B6.51B6.13B6.00B5.55B5.46B4.64B6.22B5.99B5.59B
Inventory5.95B5.48B5.22B5.29B4.62B4.31B4.23B3.75B3.58B3.34B
Current assets24.8B23.8B21.9B21.7B23.1B22.5B22.0B22.0B23.0B24.9B
Property, plant and equipment7.42B6.84B6.13B5.57B5.41B5.22B4.83B4.67B4.60B4.36B
Goodwill42.6B41.7B41.0B41.4B40.5B42.0B39.8B40.0B39.5B38.5B
Total assets93.0B91.7B90.0B90.9B91.0B93.1B90.7B89.7B91.4B99.9B
Accounts payable2.64B2.45B2.41B2.66B2.28B2.11B2.00B1.95B1.63B1.55B
Current liabilities11.7B12.9B10.8B9.05B12.4B8.51B10.4B8.47B10.1B14.3B
Long-term debt26.2B25.6B23.9B24.3B20.4B26.4B22.1B24.6B23.7B25.9B
Total debt24.9B25.4B25.8B33.4B
Total liabilities43.0B43.4B39.6B39.3B38.3B41.5B39.8B39.5B40.6B49.5B
Shareholders' equity49.5B48.0B50.2B51.5B52.6B51.4B50.7B50.1B50.7B50.2B
Shares outstanding1.28B1.28B1.31B1.33B1.33B1.35B1.34B1.34B1.35B1.37B

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations7.33B7.04B6.79B6.04B7.35B6.24B7.23B7.01B4.68B6.88B
Capital spending-1.90B-1.86B-1.59B-1.46B-1.37B-1.35B-1.21B-1.13B-1.07B-1.25B
Free cash flow5.43B5.18B5.20B4.58B5.98B4.88B6.02B5.87B3.62B5.63B
Cash from investing-2.93B-1.94B-2.37B-3.49B-1.66B-2.87B-3.20B-774.0M5.86B-1.57B
Cash from financing-4.75B-4.36B-4.45B-4.96B-5.34B-4.14B-4.20B-5.43B-12.0B-3.28B
Dividends paid-3.64B-3.59B-3.67B-3.62B-3.38B-3.12B-2.89B-2.69B-2.49B-2.38B
Share buybacks-1.03B-3.23B-2.14B-645.0M-2.54B-652.0M-1.33B-2.88B-2.17B-3.54B
Change in cash-269.0M934.0M-259.0M-2.17B121.0M-547.0M-253.0M724.0M-1.30B2.09B